MDM2 and plasma cell myeloma: USP7 inhibitors such as p5091, p220077, and p50429 enhance the ubiquitination and degradation of murine double minute 2 (MDM2), thereby inducing apoptosis in bortezomib-resistant multiple myeloma (MM) cells.